Clinical Trials Logo

Acute Myocardial Infarction clinical trials

View clinical trials related to Acute Myocardial Infarction.

Filter by:

NCT ID: NCT03551964 Not yet recruiting - Clinical trials for Acute Myocardial Infarction

Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction

DAPT-SHOCK-AMI
Start date: June 2018
Phase: Phase 4
Study type: Interventional

Multicenter randomized double blind trial comparing intravenous cangrelor and oral ticagrelor in patients with acute myocardial infarction complicated by initial cardiogenic shock and treated with primary angioplasty.

NCT ID: NCT03528382 Recruiting - Clinical trials for Acute Myocardial Infarction

The Impact of Early Cardiac Rehabilitation of AMI Patients on the Incidence of Post-infarction HF

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

Background: Acute myocardial infarction (AMI) is the second cause of death worldwide. After AMI, the heart failure (HF) is a main cause of patient rehospitalization and death. Despite the total ischemic time of AMI is decreasing in general at present, the incidence of HF after AMI remains high. The incidence of HF in Switzerland and the United States are 25% and 14-16%, respectively, and the epidemiological statistic of AMI in the past 10 years was lacking in China, but the rate has been exceeded 22% by conservative estimation. Early cardiac rehabilitation quality improvement system has been shown to reduce incidence of post-infarction HF and improve cardiovascular function. However, early cardiac rehabilitation has low proportion and poor quality, which lacks of standard. Objective: The purposes of this quality improvement study are to evaluate a pointed, two-phase intervention system to improve the proportion and quality of cardiac rehabilitation; to standardize the early cardiac rehabilitation procedure to improve the prognosis among patients with post-infarction HF. Methods: Including the period I of cardiac rehabilitation, pre-discharge (baseline) assessment and the period II of cardiac rehabilitation. Statistical analysis: Data analyses are performed using the software package SAS version 9.2 and all tests are 2-sided with P<0.05 denoting statistical significance. Quantitative data changes between groups which are compared with using the paired Student`s t test and Wilcoxon rank sum test according to the data distribution, and categorical data is analyzed by chi-square test and ranked data is analyzed by Wilcoxon rank sum test. The investigator compare the incidence of heart failure in early rehabilitation patients between two phases according to the chi-square test of the rate of two groups, to explore the role of early cardiac rehabilitation after AMI in reducing the incidence of HF after AMI.

NCT ID: NCT03494751 Not yet recruiting - Clinical trials for Acute Myocardial Infarction

Heart Monitoring Device After Acute Myocardium Infarction

Monitor
Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Verify the effectiveness of a Heart Monitor in preventing events in patients over 18 years after acute myocardial infarction in a clinical unit. Patients with neurological disease or congenital heart disease we excluded from the study.

NCT ID: NCT03487445 Not yet recruiting - Clinical trials for Acute Myocardial Infarction

A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack

Start date: July 16, 2018
Phase: Phase 2
Study type: Interventional

The goal of this study is to find out how fast a drug called ACT-246475 can prevent platelets from binding together. This study will also help to find out more about the safety of this new drug. The drug ACT-246475 will be used in 2 different doses (8 mg or 16 mg) and will be administered in the thigh.

NCT ID: NCT03486080 Not yet recruiting - Clinical trials for Acute Myocardial Infarction

Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction

Start date: June 2018
Phase: Phase 2
Study type: Interventional

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction

NCT ID: NCT03481257 Completed - Clinical trials for Acute Coronary Syndrome

Comparison Between Ticagrelor Versus Very Low Dose Rivaroxaban With Clopidogrel

Start date: April 12, 2017
Phase:
Study type: Observational

A total of 50 participants diagnosed with ACS (group A ticagrelor 180mg/d, n=25), group B (clopidogrel 75mg + rivaroxaban 5mg/ d, n=25)) were consecutively enrolled and treated with study drugs on top of aspirin (100mg/d) for 1 month. VerifyNow® and Global thrombosis test were performed at day 2 and 1 month after administration of study drugs. The investigators compared aspirin reaction unit (ARU) and P2Y12 reaction unit (PRU), occlusion time (OT) which reflects shear stress-induced thrombotic activity, and lysis time (LT) which showed endogenous lytic activity between the two strategies at both time points.

NCT ID: NCT03470441 Not yet recruiting - Clinical trials for Acute Myocardial Infarction

A Study of Acute Myocardial Infarction Using FDY-5301

Start date: March 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, efficacy, and pharmacokinetics (PK) of three dose levels of FDY-5301 compared to placebo in STEMI patients undergoing PCI.

NCT ID: NCT03462498 Recruiting - Clinical trials for Coronary Artery Disease

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS

STOPDAPT-2 ACS
Start date: April 2, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the safety of reducing dual antiplatelet therapy (DAPT) duration to 1 month after implantation of the everolimus-eluting cobalt-chromium stent (CoCr-EES) under the setting of acute coronary syndrome (ACS).

NCT ID: NCT03462225 Not yet recruiting - Clinical trials for Acute Myocardial Infarction

Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells With Acute Myocardial Infarction

Start date: December 2018
Phase: Phase 1
Study type: Interventional

This study is a first-in-human assessment of safety of using UCMSC in patients with AMI via a combination of IC and IV stem cell administration. The novelty of the current UMSC01 treatment study is the dual route of administration. Since dual administration of UCMSC via IC and IV had never been conducted in humans, there may be unknown risks to humans not predicted from the preclinical studies. However, the risk to patients in this trial will be minimized by rigorous adherence to the eligibility criteria, use of appropriate dose and concentration of stem cells, standardized techniques of stem cell infusion, and intensive patient monitoring during and after stem cell infusion.

NCT ID: NCT03454841 Recruiting - Clinical trials for Acute Myocardial Infarction

Daily Variability of Platelet Aggregation in Patients With Myocardial Infarction Treated With Prasugrel and Ticagrelor

DRAGON
Start date: February 26, 2018
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare circadian variability of antiplatelet effect of prasugrel and ticagrelor maintenance doses during the initial days after acute myocardial infarction.